Biomarkers in translational research: Focus on discovery, development and translation of protein biomarkers to clinical immunoassays

Expert Review of Molecular Diagnostics

Volumn 7, Issue 5, 2007, Pages 545-553

  Rai, Alex J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Assay development; Biomarker; Clinical laboratory testing; Translational research

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; TUMOR MARKER; ANTIBODY; PROTEIN;

ANTIGEN ANTIBODY REACTION; CLINICAL LABORATORY; CLINICAL RESEARCH; DISEASE COURSE; ELECTROPHORESIS; ENZYME ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOASSAY; NEPHELOMETRY; NONHUMAN; PHOTOMETRY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN TARGETING; QUANTITATIVE ASSAY; REVIEW; SPECTROPHOTOMETRY; TRANSLATION REGULATION; TURBIDIMETRY; ANTIGEN ANTIBODY COMPLEX; BLOOD; GENETICS; METHODOLOGY; NEOPLASM; PROTEIN SYNTHESIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL MARKERS; BLOOD PROTEINS; HUMANS; IMMUNOASSAY; NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 35148875925     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.7.5.545     Document Type: Review

References (20)

1. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2005).
2. Fundamentals of Clinical Chemistry. Burtis CA, Ashwood ER, Tietz NW (Eds). WB Saunders Company PA, USA (2001).
3. Omenn GS, States DJ, Adamski M et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5(13), 3226-3245 (2005).
4. Anderson NL, Anderson NG. The human plasma proteome: history character, and diagnostic prospects. Mol. Cell. Proteomics 1(11), 845-867 (2002).
5. Rai AJ, Gelfand CA, Haywood BC et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5(13), 3262-3277 (2005).
6. Rai AJ, Vitzthum F. Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Rev. Proteomics 3(4), 409-426 (2006).
7. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24(8), 971-983 (2006).
8. Vitzthum F, Behrens F, Anderson NL, Shaw JH. Proteomics: from basic research to diagnostic application. A review of requirements and needs. J. Proteome Res, 4(4), 1086-1097 (2005).
9. Qian KR, Jacobs JM, Liu T, Camp DG 2nd, Smith RD. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell. Proteomics 5(10), 1727-1744 (2006).
10. Choe LH, Werner BG, Lee KH. Two-dimensional protein electrophoresis from molecular pathway discovery to biomarker discovery in neurological disorders. NeuroRx 3(3), 327-335 (2006).
11. Ackermann BL, Hale JE, Duffin KL. The role of mass spectrometry in biomarker discovery and measurement. Curr. Drug Metab. 7(5), 525-539 (2006).
12. Fu Q, Van Eyk JE. Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev. Proteomics 3(2), 237-249 (2006).
13. Immunoassay - A Practical Guide. Chan DW (Ed.). Academic Press Inc., San Diego, CA, USA (1987).
14. Quantitative Immunoassay: A Practical Guide for Assay Establishment, Troubleshooting and Clinical Application. Wu JT (Ed.). AACC Press, Washington, DC, USA (2000).
15. Haasnoot W, du Pre JG. Luminex based triplex immunoassay for the simultaneous detection of soy, pea, and soluble wheat proteins in milk powder. J. Agric. Food Chem. 55, 3771-3777 (2007).
16. Waterboer T, Sehr P, Michael KM et al. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin. Chem. 51(10), 1845-1853 (2005).
17. Aziz KJ. Tumor markers: reclassification and new approaches to evaluation. Adv. Clin. Chem. 33, 169-199 (1999).
18. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359(9306), 572-577 (2002).
19. Coombes KR et al. Serum proteomics profiling - a young technology begins to mature. Nat. Biotechnol. 23(3), 291-292 (2005).
20. Diamandis EP. Analysis of serum proteomic patterns for early cancer dagnosis: drawing attention to potential problems. J. Natl Cancer Inst. 96(5), 353-356 (2004).